拉喹莫德抑制劑Laquinimod is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy.
| 產(chǎn)品名稱： | 拉喹莫德 | ||
| 英文名： | Laquinimod | ||
| CAS NO.： | 248281-84-7 | ||
| 分子式： | C19H17ClN2O3 | ||
| 分子量： | 356.802883863449 | ||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 1mg | ||
